<DOC>
	<DOC>NCT01795001</DOC>
	<brief_summary>The purpose of this study is to gain further insights into the molecular pathogenesis of Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug therapy.</brief_summary>
	<brief_title>The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
	<mesh_term>Iridocorneal Endothelial Syndrome</mesh_term>
	<criteria>FECD normal corneas (including enucleations for uveal melanoma) nonFECD oedematous corneas prior irradiation therapy for uveal melanoma corneal extension of uveal melanoma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>pathophysiology</keyword>
</DOC>